Personalized ADHD drug shows promise in early trial for teens
NCT ID NCT02286817
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This early-stage study tested a drug called NFC-1 in 30 adolescents aged 12-17 with ADHD who also have specific genetic changes affecting brain receptors. The goal was to check the drug's safety and how the body processes it, while also looking for signs it might reduce ADHD symptoms. Participants received a single dose followed by four weeks of daily treatment, with results compared to a placebo group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NFC-1 (a drug targeting glutamate receptors in the brain)
- What this could lead to
- If successful, this could point toward a personalized treatment for ADHD in teens with specific genetic changes.
- What could go wrong
- This is an early Phase 1 trial with only 30 participants, so results may not apply widely. The drug may not improve ADHD symptoms or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Thomas Jefferson University, Clinical Research Unit
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could dancing sharpen the minds of children with ADHD?
- Can a 12-Week play program boost development in At-Risk infants?
- Zapping the brain to sharpen focus: a new hope for adult ADHD?
- Can a phone app curb risky drinking in young adults with ADHD?
- Could a cannabis compound help teens with ADHD?
- Could a plant extract ease ADHD in adults? new trial results are in